UNITED THERAPEUTICS Corp - Common Stock (UTHR)

CUSIP: 91307C102

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
43,898,805
Total 13F shares
43,992,356
Share change
+176,742
Total reported value
$15,526,430,783
Put/Call ratio
85%
Price per share
$352.84
Number of holders
667
Value change
+$60,965,879
Number of buys
335
Number of sells
253

Quarterly Holders Quick Answers

What is CUSIP 91307C102?
CUSIP 91307C102 identifies UTHR - UNITED THERAPEUTICS Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of UTHR - UNITED THERAPEUTICS Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F
Company
12%
5,317,397
$1,905,489,216 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
10%
4,409,610
$1,580,183,745 30 Sep 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
7.2%
3,170,849
$1,136,273,739 30 Sep 2024
13F
Avoro Capital Advisors LLC
13F
Company
6.5%
2,858,888
$1,024,482,515 30 Sep 2024
13F
STATE STREET CORP
13F 13D/G
Company · STATE STREET CORPORATION
4.9%
from 13D/G
2,238,224
$802,067,570 30 Sep 2024
RENAISSANCE TECHNOLOGIES LLC
13F
Company
4.9%
2,155,392
$772,384,723 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.5%
1,094,015
$391,458,842 30 Sep 2024
13F
FMR LLC
13F
Company
2.5%
1,077,628
$386,168,049 30 Sep 2024
13F
LSV ASSET MANAGEMENT
13F
Company
2.2%
969,465
$347,408,000 30 Sep 2024
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
2.2%
967,734
$346,787,479 30 Sep 2024
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
1.5%
641,599
$229,917,002 30 Sep 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.4%
621,032
$222,548,466 30 Sep 2024
13F
FULLER & THALER ASSET MANAGEMENT, INC.
13F
Company
1.3%
568,392
$203,683,276 30 Sep 2024
13F
Pacer Advisors, Inc.
13F
Company
1.3%
566,703
$203,078,020 30 Sep 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
1.3%
551,680
$197,694,528 30 Sep 2024
13F
JANUS HENDERSON GROUP PLC
13F
Company
1%
460,419
$164,978,041 30 Sep 2024
13F
NORGES BANK
13F
Company
0.97%
423,632
$151,808,527 30 Sep 2024
13F
ASSETMARK, INC
13F
Company
0.96%
419,957
$150,491,591 30 Sep 2024
13F
Swedbank AB
13F
Company
0.95%
414,937
$148,692,676 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
0.91%
401,463
$143,864,507 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
0.91%
401,117
$143,740,386 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.86%
378,556
$135,655,542 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.84%
369,955
$132,573,374 30 Sep 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.82%
359,563
$128,849,402 30 Sep 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.78%
344,527
$123,462,000 30 Sep 2024
13F
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC
13F
Individual
0.78%
343,744
$123,180,659 30 Sep 2024
13F
Invesco Ltd.
13F
Company
0.67%
293,985
$105,349,524 30 Sep 2024
13F
FIRST TRUST ADVISORS LP
13F
Company
0.63%
277,089
$99,294,834 30 Sep 2024
13F
FRANKLIN RESOURCES INC
13F
Company
0.57%
250,719
$89,531,756 30 Sep 2024
13F
Epoch Investment Partners, Inc.
13F
Company
0.54%
238,786
$85,568,963 30 Sep 2024
13F
HSBC HOLDINGS PLC
13F
Company
0.51%
225,242
$80,656,236 30 Sep 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.48%
212,657
$76,205,637 30 Sep 2024
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.48%
211,822
$75,906,414 30 Sep 2024
13F
LORD, ABBETT & CO. LLC
13F
Company
0.46%
201,695
$72,277,000 30 Sep 2024
13F
Robeco Institutional Asset Management B.V.
13F
Company
0.45%
196,019
$70,243,409 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.44%
192,546
$68,998,858 30 Sep 2024
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.43%
186,819
$66,946,589 30 Sep 2024
13F
Palo Alto Investors LP
13F
Company
0.42%
183,246
$65,666,204 30 Sep 2024
13F
Legal & General Group Plc
13F
Company
0.42%
182,788
$65,502,082 30 Sep 2024
13F
Clark Capital Management Group, Inc.
13F
Company
0.42%
182,288
$65,322,905 30 Sep 2024
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.41%
181,305
$64,970,737 30 Sep 2024
13F
FRONTIER CAPITAL MANAGEMENT CO LLC
13F
Company
0.41%
179,154
$64,199,782 30 Sep 2024
13F
COMERICA BANK
13F
Company
0.39%
170,295
$61,025,296 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.38%
167,831
$60,142,238 30 Sep 2024
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.38%
165,802
$59,444,991 30 Sep 2024
13F
LOOMIS SAYLES & CO L P
13F
Company
0.34%
148,481
$53,208,000 30 Sep 2024
13F
CITIGROUP INC
13F
Company
0.34%
147,979
$53,028,275 30 Sep 2024
13F
TD ASSET MANAGEMENT INC
13F
Company
0.32%
142,366
$51,042,482 30 Sep 2024
13F
Polaris Capital Management, LLC
13F
Company
0.32%
141,950
$50,867,783 30 Sep 2024
13F
Eversept Partners, LP
13F
Company
0.3%
130,949
$46,925,574 30 Sep 2024
13F

Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q4 2024

As of 31 Dec 2024, UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by 667 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,992,356 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, AQR CAPITAL MANAGEMENT LLC, and LSV ASSET MANAGEMENT. This page lists 670 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
617
Q4 2024 holders
667
Holder diff
50
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .